Jupiter Investment Management’s Teladoc Health TDOC Stock Holding History

Jupiter Investment Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$497K	Buy	+2,607	New	+$457K	0.01%	321

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jupiter Investment Management's TDOC Position: Q2 2020 in Review

Jupiter Investment Management opened a new position in Teladoc Health (TDOC) in Q2 2020: 2,607 shares worth $497K. The stake represents 0.01% of the portfolio and ranks #321 among its holdings.

669 funds tracked by Wall St. Rank hold TDOC as of Q2 2020.

Jupiter Investment Management held 2,607 shares of Teladoc Health worth $497K as of Q2 2020.
Teladoc Health was a new Jupiter Investment Management position in Q2 2020.
Teladoc Health made up 0.01% of Jupiter Investment Management's portfolio in Q2 2020, its #321 holding.
669 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.